CIK: 0001687078 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value ($000): $666,571 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 7,648,268 | $128,032 | 19.2% | $40.60 | -56.3% | Common | 230031106 |
| INSM | Insmed Incorporated | 615,391 | $44,924 | 6.7% | $21.93 | +236.5% | Common | 457669307 |
| OLMA | Olema Pharmaceuticals, Inc. | 2,680,596 | $32,006 | 4.8% | $9.74 | +31.3% | Common | 68062P106 |
| RNAM | Avidity Biosciences Inc | 688,975 | $31,645 | 4.7% | $40.73 | +6.5% | Common | 05370A108 |
| CRNX | Crinetics Pharmaceuticals Inc. | 525,845 | $26,871 | 4.0% | $24.65 | +109.2% | Common | 22663K107 |
| EWTX | Edgewise Therapeutics Inc | 917,166 | $24,479 | 3.7% | $17.17 | +15.9% | Common | 28036F105 |
| IOVA | Iovance Biotherapeutics Inc | 2,406,714 | $22,599 | 3.4% | $10.02 | -5.5% | Common | 462260100 |
| NTRA | Natera Inc | 177,099 | $22,483 | 3.4% | $76.08 | +50.9% | Common | 632307104 |
| RCKT | Rocket Pharmaceuticals, Inc. | 1,066,373 | $19,696 | 3.0% | $20.48 | 0.0% | Common | 77313F106 |
| MIRM | Mirum Pharmaceuticals Inc | 492,723 | $19,216 | 2.9% | $26.22 | +52.2% | Common | 604749101 |
| RARE | Ultragenyx Pharmaceutical Inc | 329,733 | $18,317 | 2.7% | $45.58 | +11.7% | Common | 90400D108 |
| — | iTeos Therapeutics, Inc. | 1,745,943 | $17,826 | 2.7% | $24.67 | — | Common | 46565G104 |
| MLTX | Moonlake Immunotherapeutics | 349,063 | $17,600 | 2.6% | $29.33 | +59.8% | Class A Ord | 61559X104 |
| LNTH | Lantheus Holdings Inc | 150,182 | $16,482 | 2.5% | $73.36 | +41.6% | Common | 516544103 |
| MDGL | Madrigal Pharmaceuticals Inc | 72,395 | $15,364 | 2.3% | $180.07 | +42.1% | Common | 558868105 |
| IRON | Disc Medicine Inc | 311,761 | $15,320 | 2.3% | $43.01 | +9.2% | Common | 254604101 |
| RLAY | Relay Therapeutics Inc. | 2,033,041 | $14,394 | 2.2% | $11.40 | -34.5% | Common | 75943R102 |
| TWST | Twist Bioscience Corp | 294,930 | $13,325 | 2.0% | $47.58 | 0.0% | Common | 90184D100 |
| RVMD | Revolution Medicines, Inc. | 291,391 | $13,215 | 2.0% | $27.55 | +58.0% | Common | 76155X100 |
| GH | Guardant Health Inc | 499,170 | $11,451 | 1.7% | $23.27 | +21.6% | Common | 40131M109 |
| — | Akero Therapeutics Inc | 392,544 | $11,262 | 1.7% | $25.07 | — | Common | 00973Y108 |
| KALV | Kalvista Pharmaceuticals Inc | 896,915 | $10,386 | 1.6% | $13.09 | -4.0% | Common | 483497103 |
| CMPX | Compass Therapeutics, Inc. | 5,641,894 | $10,381 | 1.6% | $1.53 | -18.5% | Common | 20454B104 |
| RNAC | Cartesian Therapeutics Inc | 629,423 | $10,146 | 1.5% | $19.03 | -17.9% | Common | 816212302 |
| — | Sutro Biopharma, Inc. | 2,832,064 | $9,799 | 1.5% | $5.65 | — | Common | 869367102 |
| AQST | Aquestive Therapeutics Inc | 1,796,750 | $8,948 | 1.3% | $3.89 | 0.0% | Common | 03843E104 |
| JANX | Janux Therapeutics Inc | 171,105 | $7,773 | 1.2% | $43.50 | 0.0% | Common | 47103J105 |
| VKTX | VIKING THERAPEUTICS INC | 120,982 | $7,659 | 1.1% | $15.04 | +290.0% | Common | 92686J106 |
| XENE | Xenon Pharmaceuticals Inc | 165,800 | $6,528 | 1.0% | $40.32 | 0.0% | Common | 98420N105 |
| STOK | Stoke Therapeutics Inc | 479,452 | $5,892 | 0.9% | $14.17 | 0.0% | Common | 86150R107 |
| — | Repare Therapeutics, Inc. | 1,639,849 | $5,641 | 0.8% | $31.02 | — | Common | 760273102 |
| NTLA | Intellia Therapeutics, Inc. | 267,557 | $5,498 | 0.8% | $70.53 | -67.3% | Common | 45826J105 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 1,465,801 | $5,394 | 0.8% | $13.65 | -73.4% | Common | 98943L107 |
| TRVI | Trevi Therapeutics Inc | 1,538,517 | $5,139 | 0.8% | $2.31 | +29.0% | Common | 89532M101 |
| WVE | Wave Life Sciences PTE LTD | 624,471 | $5,121 | 0.8% | $5.98 | 0.0% | Common | Y95308105 |
| ARCT | Arcturus Therapeutics Holdings | 219,508 | $5,095 | 0.8% | $21.39 | 0.0% | Common | 03969T109 |
| HOWL | Werewolf Therapeutics, Inc. | 2,388,011 | $5,063 | 0.8% | $13.70 | -83.4% | Common | 95075A107 |
| ADAPY | Adaptimmune Therapeutics plc | 5,095,912 | $4,841 | 0.7% | $0.93 | — | Sponsored ADR | 00653A107 |
| ALXO | ALX Oncology Holdings Inc. | 2,409,862 | $4,386 | 0.7% | $10.00 | -62.8% | Common | 00166B105 |
| PTCT | PTC Therapeutics Inc | 89,715 | $3,328 | 0.5% | $33.48 | 0.0% | Common | 69366J200 |
| — | 89Bio Inc | 330,000 | $2,442 | 0.4% | $11.14 | — | Common | 282559103 |
| RGNX | REGENXBIO Inc. | 50,000 | $525 | 0.1% | $28.86 | -57.8% | Common | 75901B107 |
| SLDB | Solid Biosciences Inc | 11,518 | $80 | 0.0% | $8.11 | 0.0% | Common | 83422E204 |